MT1JP inhibits tumorigenesis and enhances cisplatin sensitivity of breast cancer cells through competitively binding to miR-24-3p.

Zhu, Donglei; Zhang, Xia; Lin, Yun; Liang, Shujing; Song, Zhiwang; Dong, Chunyan

Zhu, Donglei; Zhang, Xia; Lin, Yun; Liang, Shujing; Song, Zhiwang; Dong, Chunyan.

Afiliação

Zhu D; Department of Oncology, Shanghai East Hospital, Tongji University School of Medicine Shanghai, People's Republic of China.
Zhang X; Department of Oncology, Shanghai East Hospital, Tongji University School of Medicine Shanghai, People's Republic of China.
Lin Y; Department of Oncology, Shanghai East Hospital, Tongji University School of Medicine Shanghai, People's Republic of China.
Liang S; Department of Oncology, Shanghai East Hospital, Tongji University School of Medicine Shanghai, People's Republic of China.
Song Z; Department of Oncology, Shanghai East Hospital, Tongji University School of Medicine Shanghai, People's Republic of China.
Dong C; Department of Oncology, Shanghai East Hospital, Tongji University School of Medicine Shanghai, People's Republic of China.

Am J Transl Res ; 11(1): 245-256, 2019.

Article em En | MEDLINE | ID: mdl-30787983

Palavras-chave

MT1JP; breast cancer; cisplatin; miR-24-3p; proliferation

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Diagnostic_studies Idioma: En Revista: Am J Transl Res Ano de publicação: 2019 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google